Finance

Zoetis subsidiary Pharmaq snaps up Benchmark's fish health division

The company has a strategy of shedding its non-core activities.

Benchmark CEO Trond Williksen. The fish health and aquaculture genetics group has continued to focus operations by selling off non-core divisions.
Benchmark CEO Trond Williksen. The fish health and aquaculture genetics group has continued to focus operations by selling off non-core divisions.
Published 1 July 2020, 06:12Updated 1 July 2020, 17:55
BenchmarkPharmaqFishVetFish healthVaccines